Ligature Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Liquidation

Ligature Therapeutics General Information

Description

Developer of a biotechnology research platform designed to offer tumour-selective targeted protein degraders. The company's platform uses a structure-agnostic, proprietary Fragment-Based Drug Discovery (FBDD) engine to maximize efficiencies and match underexploited, tumor-selective E3 ligases with cancer target proteins, enabling patients to get the required treatment for difficult-to-treat cancers and other intractable diseases.

Contact Information

Website
www.ligaturetx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Block 79, Ayer Rajah Crescent
  • Number 05-03
  • Singapore, 139955
  • Singapore
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Surgical Devices
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Block 79, Ayer Rajah Crescent
  • Number 05-03
  • Singapore, 139955
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ligature Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 19-Mar-2023 Completed Bankruptcy: Liquidation
1. Seed Round 04-Jan-2021 Completed Generating Revenue
To view Ligature Therapeutics’s complete valuation and funding history, request access »

Ligature Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Ligature Therapeutics’s complete cap table history, request access »

Ligature Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Ligature Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11504381-B1 Therapeutic compounds and methods of use thereof Active 22-Nov-2021
US-11548866-B1 Therapeutic compounds and methods of use thereof Active 22-Nov-2021
WO-2023089375-A1 Therapeutic compounds and methods of use thereof Inactive 22-Nov-2021 C07D401/04

Ligature Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Ligature Therapeutics FAQs

  • When was Ligature Therapeutics founded?

    Ligature Therapeutics was founded in 2020.

  • Where is Ligature Therapeutics headquartered?

    Ligature Therapeutics is headquartered in Singapore, Singapore.

  • What is the size of Ligature Therapeutics?

    Ligature Therapeutics has 6 total employees.

  • What industry is Ligature Therapeutics in?

    Ligature Therapeutics’s primary industry is Biotechnology.

  • Is Ligature Therapeutics a private or public company?

    Ligature Therapeutics is a Private company.

  • What is Ligature Therapeutics’s current revenue?

    The current revenue for Ligature Therapeutics is .

  • How much funding has Ligature Therapeutics raised over time?

    Ligature Therapeutics has raised $6.55M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process